Carvedilol is a non-selective adrenergic blocker indicated for the chronic therapy of heart failure with reduced ejection fraction (hfref), hypertension, and left ventricular dysfunction following myocardial infarction (mi) in clinically stable patients.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries. API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.